Literature DB >> 7372416

Heterotransplantation of human choroidal melanoma into the athymic "nude" mouse.

D M Albert, M D Wagoner, K Moazed, G P Kimball, J R Gonder.   

Abstract

The investigation of the structure and behavior of malignant melanoma of the uveal tract in man has been limited by the lack of a ready source of human tumor and an animal model in which the tumor resembles that in the human choroid. We now report the observation that fresh surgical specimens of human choroidal melanoma can be successfully transplanted into the posterior segment of the "nude" mouse (a homozygous mutant, nu/nu, with a defect in cellular immunity) and can be serially transplanted. This model utilizing human melanoma should be useful for the study of the natural history of this disease, as well as the response to various chemotherapeutic agents.

Entities:  

Mesh:

Year:  1980        PMID: 7372416

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  5 in total

Review 1.  Technical considerations for studying cancer metastasis in vivo.

Authors:  D R Welch
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

2.  Orthotopic human choroidal melanoma xenografts in nude rats with aggressive and nonaggressive PAS staining patterns.

Authors:  Rod D Braun; Asad Abbas
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-01       Impact factor: 4.799

3.  Pigmented uveal tumours in a transgenic mouse model.

Authors:  T R Kramer; M B Powell; M M Wilson; J Salvatore; H E Grossniklaus
Journal:  Br J Ophthalmol       Date:  1998-08       Impact factor: 4.638

4.  Measurement of human choroidal melanoma xenograft volume in rats using high-frequency ultrasound.

Authors:  Rod D Braun; Kerry S Vistisen
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-01       Impact factor: 4.799

5.  Heterotransplantation of human uveal melanoma.

Authors:  P E Liggett; G Lo; K J Pince; N A Rao; S G Pascal; J Kan-Mitchel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993       Impact factor: 3.117

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.